
FREE In-Pharmacy Alzheimer's & AMD Risk Factor Screening Service
Make an appointment to find out your carotenoid score!

1 minute, non-invasive test



Helps to support normal brain function* ,
- Unique patented formula
- All natural ingredients
- Just 3 daily capsules
Just
€49.95
A targeted daily boost of brain nourishing nutrients:
- 500mg Omega-3 DHA
- 150mg Omega-3 EPA
- 15mg Vitamin E
- 10mg Lutein
- 10mg Meso-Zeaxanthin
- 2mg Zeaxanthin

The patented formula that supports brain function at any age*.

Re-MIND Study now published
The Nutrition Research Centre Ireland peer-reviewed study finds that patients with Alzheimer’s disease can benefit from supplementation with carotenoids, omega-3 fatty acids and vitamin E.
This significant clinical trial has been published in the Journal of Alzheimer’s Disease

It’s Never Too Early To Start Thinking About Supporting Our Brain Function
Looking after our overall brain function is important at every age.
ReMind™ has been scientifically researched by leading scientists at South East Technological University (SETU) to investigate how it supports normal brain function 1,2,3,4,5,6.
Our patented formula combines carotenoids and the power of Omega-3 for the maintenance of brain function.

It’s Never Too Early To Start Thinking About Supporting Our Brain Function
Looking after our overall brain function is important at every age.
ReMind™ has been scientifically researched by leading scientists at South East Technological University (SETU) to investigate how it supports normal brain function 1,2,3,4,5,6.
Our patented formula combines carotenoids and the power of Omega-3 for the maintenance of brain function.
- Scientifically researched in South East Technological University reMIND trials6
- Supplement Certified Seal of Approval
- No prescription required
- Helps maintain normal brain function*
- Patented formula
- No side effects

1 minute, non-invasive test


FREE In-Pharmacy Alzheimer's & AMD Risk Factor Screening Service
Make an appointment to find out your carotenoid score!
Meet our Ingredients
The ReMind™ formulation was specifically designed to reflect the very latest scientific understanding of brain nutrition. The active ingredients in the ReMind formulation are already found in the brain.
Omega-3 fatty acids are one of the key building blocks of the brain, with DHA fatty acids making up 40% of our brain. Carotenoids have been discovered in both our eyes (at the macula) and our brains.
ReMind™ gives you a targeted daily dose of:
- 500mg Omega-3 DHA
- 150mg Omega-3 EPA
- 15mg Vitamin E
- 10mg Lutein
- 10mg Meso-Zeaxanthin
- 2mg Zeaxanthin
15% OFF when you sign up to our email updates!
*DHA contributes to the maintenance of normal brain function. The beneficial effect is obtained with a daily intake of 250mg DHA. ReMind™ provides 500mg DHA per daily serving.
1. Low macular pigment optical density is associated with lower cognitive performance in a large, population-based sample of older adults. Feeney J, Nolan JM, et al, Neurobiology of Aging, 2013.
2. The impact of supplemental macular carotenoids in Alzheimer’s disease: a randomized clinical trial. Nolan JM, Loskutova E et al, Journal of Alzheimers Disease, 2015.
3. Nutritional Intervention to Prevent Alzheimer’s Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined. Nolan JM, Mulcahy R, et al, Journal of Alzheimer’s Disease, 2018.
4. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. R Power, Nolan JM et al, Journal of Alzheimer’s Disease, 2018.
5. Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial. R Power, Nolan JM et al, Clinical Nutrition , 2021.
6. Nolan JM, et al. ‘Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer’s Disease’ Re-MIND (Memory Investigation with Nutrition for Dementia) Trial. J Alzheimers Dis. 2022:233–249.